Literature DB >> 12660925

Chlamydia pneumoniae infection of alveolar macrophages: a model.

Shusaku Haranaga1, Hiroyuki Yamaguchi, Hideaki Ikejima, Herman Friedman, Yoshimasa Yamamoto.   

Abstract

Chlamydia (Chlamydophila) pneumoniae is a common respiratory pathogen, and it seems likely that alveolar macrophages may have an important role in infection with this bacterium. In the present study, we examined the usefulness of a continuous cell line of murine alveolar macrophages, designated "MH-S," as an in vitro C. pneumoniae infection model. Infection of MH-S cells with C. pneumoniae resulted in the development of typical inclusion bodies in the cells, similar to that seen in primary alveolar macrophages. However, we noted that, although the number of bacteria in the cultures increased during the infection, there was a restricted production of infective elementary bodies. The analysis of bacterial messenger RNA in the cultures showed that the message levels for the omcB gene were present only at a moderate level, but the levels of hsp60 messages increased markedly during infection. Neutralization of tumor necrosis factor (TNF)-alpha induced by inoculation with antibody significantly enhanced the infection, but omcB message levels were still inhibited. These results indicate that the growth of C. pneumoniae in alveolar macrophages may be restricted. Endogenous TNF-alpha may be one of the factors responsible for such restriction, but other factors also may be involved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12660925     DOI: 10.1086/368168

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

1.  Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts.

Authors:  Laura Mannonen; Eveliina Markkula; Mirja Puolakkainen
Journal:  Med Microbiol Immunol       Date:  2011-01-30       Impact factor: 3.402

2.  Virulent Coxiella burnetii pathotypes productively infect primary human alveolar macrophages.

Authors:  Joseph G Graham; Laura J MacDonald; S Kauser Hussain; Uma M Sharma; Richard C Kurten; Daniel E Voth
Journal:  Cell Microbiol       Date:  2013-01-14       Impact factor: 3.715

3.  Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Leena Erkkilä; Taina Korhonen; Terttu Tiirola; Aini Bloigu; Pekka Saikku; Maija Leinonen
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

4.  Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae.

Authors:  Riho Takano; Hiroyuki Yamaguchi; Shigehiro Sugimoto; Shinichi Nakamura; Herman Friedman; Yoshimasa Yamamoto
Journal:  Curr Microbiol       Date:  2005-03-15       Impact factor: 2.188

5.  Atg7 deficiency impairs host defense against Klebsiella pneumoniae by impacting bacterial clearance, survival and inflammatory responses in mice.

Authors:  Yan Ye; Xuefeng Li; Wenxue Wang; Kiswendsida Claude Ouedraogo; Yi Li; Changpei Gan; Shirui Tan; Xikun Zhou; Min Wu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-07-03       Impact factor: 5.464

6.  Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.

Authors:  Kelly L Asquith; Jay C Horvat; Gerard E Kaiko; Alison J Carey; Kenneth W Beagley; Philip M Hansbro; Paul S Foster
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

Review 7.  Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors.

Authors:  Leena Hanski; Pia Vuorela
Journal:  Microorganisms       Date:  2016-11-28

8.  cIAP-1 controls innate immunity to C. pneumoniae pulmonary infection.

Authors:  Hridayesh Prakash; Daniel Becker; Linda Böhme; Lori Albert; Martin Witzenrath; Simone Rosseau; Thomas F Meyer; Thomas Rudel
Journal:  PLoS One       Date:  2009-08-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.